Changes in acute headache medication use and health care resource utilization: Results from a randomized, double-blind, placebo-controlled clinical trial evaluating galcanezumab in adults with treatment-resistant migraine (CONQUER)

Category Primary study
JournalJOURNAL OF MANAGED CARE & SPECIALTY PHARMACY
Year 2022
This article has no abstract
Epistemonikos ID: 9e562113511c68f6e2f972470e056445d988f4ea
First added on: Nov 22, 2025